About
James Williams has broad experience covering executive management of public and private companies, establishment, resourcing and financing start-up companies and hands-on research in molecular and cell biology. James has been CEO of private and listed medical device companies Argus Biomedical Pty Ltd and Resonance Health Ltd (spin-out companies from the Lions Eye Institute and UWA respectively); in both cases he oversaw regulatory approvals and market launch of first products. He co-founded, is the former CEO and remains a Director of GPCR drug discovery company Dimerix Biosciences Pty Ltd (a spin-out from the Western Australian Institute for Medical Research). In 2003, James conceived the business concept behind UWA spin-out iCeutica. He held various Executive and non-Executive roles with iCeutica until the company was sold in April 2011 for 10 times return on investment at the time of first financing. Prior to becoming involved in technology commercialisation, James was a Senior R
Position in the VCSift Database
- • 4 investors at Yuuwa Capital are tracked.
- • 1 investors hold the Co-Founder and and Investment Director role in VCSift. James Williams is one of them.
- • 162 investors are based in Perth, Western Australia, Australia.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Perth, Australia
Contact Information
Find more investors like James
Search Investors